{"id":"NCT00655863","sponsor":"Takeda","briefTitle":"Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.","officialTitle":"Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing SYR-322 Alone and Combination SYR-322 With Pioglitazone Versus Placebo on Postprandial Lipids in Subjects With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-07","primaryCompletion":"2009-12","completion":"2009-12","firstPosted":"2008-04-10","resultsPosted":"2013-05-27","lastUpdate":"2013-05-27"},"enrollment":71,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Alogliptin and Pioglitazone","otherNames":["alogliptin","SYR110322","Actos","AD-4833","SYR-322"]},{"type":"DRUG","name":"Alogliptin","otherNames":["SYR110322","SYR-322"]},{"type":"DRUG","name":"Placebo","otherNames":["Actos","AD-4833","SYR-322"]}],"arms":[{"label":"Placebo QD","type":"PLACEBO_COMPARATOR"},{"label":"Alogliptin 25 mg QD","type":"EXPERIMENTAL"},{"label":"Alogliptin 25 mg QD + Pioglitazone 30 mg QD","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to compare the efficacy of Alogliptin, once daily (QD), taken by itself and with pioglitazone on postprandial lipid measures in type 2 diabetes.","primaryOutcome":{"measure":"Change From Baseline in Postprandial Incremental Area Under the Curve for Total Triglycerides at Week 16.","timeFrame":"Baseline and Week 16.","effectByArm":[{"arm":"Placebo QD","deltaMin":-39.728,"sd":48.2481},{"arm":"Alogliptin 25 mg QD","deltaMin":-346.957,"sd":47.2251},{"arm":"Alogliptin 25 mg QD + Pioglitazone 30 mg QD","deltaMin":-293.439,"sd":51.1271}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":15},"locations":{"siteCount":2,"countries":["Netherlands","Sweden"]},"refs":{"pmids":["22237690"],"seeAlso":["http://general.takedapharm.com/content/file/pi.pdf?applicationcode=ab2d7112-8eb3-465a-8fda-35018a9eafb0&fileTypeCode=ACTOSPI"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":24},"commonTop":["Nasopharyngitis","Constipation","Dizziness","Anaemia","Hypoglycaemia"]}}